Long-term follow-up of patients undergoing renal sympathetic denervation.

Objectives: Renal denervation (RDN) proved to significantly lower blood pressure (BP) at 2-6 months in patients on and off antihypertensive drugs. Given a lack of longer-term follow-up data, our aim was to assess the safety and efficacy of RDN up to five years taking into account antihypertensive drug regimen changes over time.

Methods: In the present single-center study, patients underwent RDN for (therapy resistant) hypertension.